{"filings":[{"id":96972,"accession_number":"0001628280-26-030101","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q1 revenue $636.5M; adjusted EPS $0.16 beats prior year; book-to-bill 1.15x","event_type":"earnings","confidence":"high","bullets":["Revenue $636.5M, down 2.3% YoY from $651.3M; GAAP net loss $23.6M ($0.25 loss per share).","Adjusted net income $15.2M, adjusted diluted EPS $0.16 vs. $0.02 in Q1 2025.","Adjusted EBITDA $47.0M, up 55% from $30.3M; backlog $7.85B; book-to-bill 1.15x (3rd straight quarter >1.1x).","Full-year 2026 guidance affirmed: revenue $2.55B-$2.65B, adjusted EBITDA $190M-$220M.","CEO cites strong commercial traction and investment in new Fortrea Intelligent Technology platform."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":636500000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111363,"accession_number":"0001628280-26-011942","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q4 rev $660.5M, adj EBITDA $54M; FY adj net income $40.4M; guides 2026 rev $2.55-2.65B","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $660.5M vs $697.0M YoY; GAAP net loss $(32.5)M ($(0.35)/share) vs $(73.9)M loss in Q4 2024.","Full-year GAAP net loss $(986.2)M ($(10.81)/share) includes $797.9M non-cash goodwill impairment; adjusted net income $40.4M ($0.43/share) vs $30.1M in 2024.","Full-year adjusted EBITDA $189.9M vs $202.5M in 2024; Q4 adjusted EBITDA $54.0M vs $56.0M.","Book-to-bill Q4 1.14x, trailing twelve months 1.02x; backlog $7,728M.","2026 guidance: revenue $2.55B-$2.65B, adjusted EBITDA $190M-$220M."],"consensus_eps_estimate":null,"consensus_eps_actual":-10.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":2723400000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127974,"accession_number":"0001628280-25-053390","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-11-20T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Fortrea completes $75.7M tender offer for 7.500% Senior Secured Notes due 2030","event_type":"debt","confidence":"high","bullets":["Tender offer expired Nov 18, 2025; accepted $75,743,000 aggregate principal amount of notes.","Final proration factor of 0.154199 applied due to oversubscription above the $75,744,000 maximum.","Notes carry 7.500% coupon, due 2030; purchase reduces outstanding debt and future interest expense.","Company tendered for cash; no new debt issuance or refinancing disclosed.","Jill McConnell, CFO, signed the report on Nov 20, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127973,"accession_number":"0001628280-25-049217","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q3 revenue $701.3M, GAAP net loss $(0.17)/share; raises FY revenue guide","event_type":"earnings","confidence":"high","bullets":["Revenue $701.3M (+4% YoY); GAAP net loss $(15.9)M vs $(18.5)M loss in Q3 2024.","Adjusted EPS $0.12 vs $0.23 a year ago; adjusted EBITDA $50.7M vs $64.2M.","Book-to-bill 1.13x for Q3; backlog $7,644M; trailing 12-month book-to-bill 1.07x.","FY 2025 revenue guidance raised to $2,700-2,750M; adjusted EBITDA narrowed to $175-195M.","Cost saving initiatives on track; recent CEO transition noted as smooth."],"consensus_eps_estimate":null,"consensus_eps_actual":-10.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":2062900000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144755,"accession_number":"0001628280-25-042341","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-09-22T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Fortrea appoints William Sharbaugh as Class III director effective Sept 22, 2025","event_type":"leadership","confidence":"high","bullets":["William Sharbaugh appointed to Fortrea Board as Class III director, effective Sept 22, 2025.","Sharbaugh served as COO of PPD, Inc. from 2007-2021 and held roles at Bristol-Myers Squibb and Merck.","No committee assignments yet; will receive standard non-employee director compensation per existing policy.","Sharbaugh currently chairs Ora LLC and serves on boards of Launch Therapeutics, Alcami, and BioCare."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144754,"accession_number":"0001965040-25-000088","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Fortrea amends inducement plan, adds 2.2M shares for new hire awards","event_type":"other","confidence":"high","bullets":["Board increased shares reserved under 2025 Inducement Award Plan by 2,200,000 shares.","Plan originally established solely for Anshul Thakral; now open for other new hires.","Awards limited to new employees (or after bona fide non-employment) under Nasdaq Listing Rule 5635(c)(4).","Full text of amended plan will be filed with Q3 2025 Form 10-Q."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144753,"accession_number":"0001965040-25-000048","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q2 GAAP loss $374.9M on $309.1M goodwill impairment; raises 2025 revenue guidance","event_type":"earnings","confidence":"high","bullets":["Revenue $710.3M, +7% YoY; GAAP net loss $374.9M ($4.14 diluted loss) includes $309.1M non-cash goodwill impairment.","Adjusted net income $17.6M ($0.19 adjusted diluted EPS) vs adjusted net loss $2.3M in Q2 2024.","Book-to-bill 0.79x for quarter, backlog $7,547M; trailing 12-month book-to-bill 1.10x.","Raising FY2025 revenue guidance to $2,600-2,700M; affirming adjusted EBITDA guidance $170-200M.","New CEO Anshul Thakral joined Aug 4, succeeding interim CEO Peter Neupert who remains chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":-10.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":1361600000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163155,"accession_number":"0001965040-25-000036","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Fortrea shareholders approve amended incentive plan with 6.5M share increase","event_type":"other_material","confidence":"high","bullets":["Shareholders at June 10 annual meeting approved A&R 2023 Omnibus Incentive Plan, adding 6.5M shares to pool.","Plan amendments include minimum vesting, no dividend payment until vesting, and eliminated liberal share recycling.","All three director nominees elected: Amrit Ray, Erin L. Russell, Machelle Sanders (each with > 60M votes for).","Ratification of Deloitte & Touche as auditor for FY2025 approved (82.7M for, 0.1M against).","Advisory vote on named executive officer compensation passed with 68.1M for vs. 3.3M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163154,"accession_number":"0001193125-25-139600","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["1.01","3.03","5.03","8.01","9.01"],"status":"ready","headline":"Fortrea adopts limited-duration rights plan with 10% trigger and 50% discount","event_type":"other_material","confidence":"high","bullets":["Rights trigger if any person acquires 10%+ of common stock; other holders can buy shares at 50% discount.","Plan expires June 10, 2026; board may redeem rights at $0.001 per right.","Adopted in response to stock price dislocation and recent third-party interest to capitalize on it.","Record date for rights distribution is June 23, 2025; rights initially trade with common stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163153,"accession_number":"0001193125-25-139161","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-06-11T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Fortrea names Anshul Thakral as permanent CEO effective August 4, 2025","event_type":"leadership","confidence":"high","bullets":["Anshul Thakral appointed President and CEO, effective August 4, 2025; replaces interim CEO Peter Neupert who remains chairman.","Thakral has over 20 years experience in CRO, pharma, and biotech; Co-founder/CEO of Launch Therapeutics since 2022.","Offer letter includes $1.1M base salary, 150% target bonus, and inducement equity grants of ~$12.5M (RSUs+PSAs) tied to performance.","Thakral also appointed Class III director; his term expires at 2026 annual meeting.","Severance plan amended to include CEO; equity grants outside 2023 Omnibus Incentive Plan (Nasdaq inducement exception)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163150,"accession_number":"0001193125-25-120888","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K/A","filed_at":"2025-05-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Fortrea appoints Erin Russell to Audit Committee effective May 13, 2025","event_type":"other_material","confidence":"high","bullets":["Board appointed Erin Russell to Audit Committee on May 9, 2025, effective May 13, 2025.","Russell was elected to the Board on March 7, 2025; committee assignment now disclosed.","No other changes from the original 8-K filed March 10, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}